These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19245716)

  • 1. Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer.
    Ross PL; Cheng I; Liu X; Cicek MS; Carroll PR; Casey G; Witte JS
    BMC Cancer; 2009 Feb; 9():69. PubMed ID: 19245716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel imprinted carboxypeptidase A4 gene ( CPA4) in the 7q32 imprinting domain.
    Kayashima T; Yamasaki K; Yamada T; Sakai H; Miwa N; Ohta T; Yoshiura K; Matsumoto N; Nakane Y; Kanetake H; Ishino F; Niikawa N; Kishino T
    Hum Genet; 2003 Mar; 112(3):220-6. PubMed ID: 12552318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection.
    Hughes L; Zhu F; Ross E; Gross L; Uzzo RG; Chen DY; Viterbo R; Rebbeck TR; Giri VN
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):53-60. PubMed ID: 22144497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication of prostate cancer risk loci in a Japanese case-control association study.
    Yamada H; Penney KL; Takahashi H; Katoh T; Yamano Y; Yamakado M; Kimura T; Kuruma H; Kamata Y; Egawa S; Freedman ML
    J Natl Cancer Inst; 2009 Oct; 101(19):1330-6. PubMed ID: 19726753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.
    Zheng SL; Sun J; Cheng Y; Li G; Hsu FC; Zhu Y; Chang BL; Liu W; Kim JW; Turner AR; Gielzak M; Yan G; Isaacs SD; Wiley KE; Sauvageot J; Chen HS; Gurganus R; Mangold LA; Trock BJ; Gronberg H; Duggan D; Carpten JD; Partin AW; Walsh PC; Xu J; Isaacs WB
    J Natl Cancer Inst; 2007 Oct; 99(20):1525-33. PubMed ID: 17925536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocalyxin variants and risk of prostate cancer and tumor aggressiveness.
    Casey G; Neville PJ; Liu X; Plummer SJ; Cicek MS; Krumroy LM; Curran AP; McGreevy MR; Catalona WJ; Klein EA; Witte JS
    Hum Mol Genet; 2006 Mar; 15(5):735-41. PubMed ID: 16434482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients.
    He Y; Gu J; Strom S; Logothetis CJ; Kim J; Wu X
    Clin Cancer Res; 2014 Oct; 20(19):5133-5139. PubMed ID: 25274378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of testis derived transcript gene variants and prostate cancer risk.
    Liu X; Cicek MS; Plummer SJ; Jorgenson E; Casey G; Witte JS
    J Urol; 2007 Mar; 177(3):894-8. PubMed ID: 17296370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.
    Helfand BT; Roehl KA; Cooper PR; McGuire BB; Fitzgerald LM; Cancel-Tassin G; Cornu JN; Bauer S; Van Blarigan EL; Chen X; Duggan D; Ostrander EA; Gwo-Shu M; Zhang ZF; Chang SC; Jeong S; Fontham ET; Smith G; Mohler JL; Berndt SI; McDonnell SK; Kittles R; Rybicki BA; Freedman M; Kantoff PW; Pomerantz M; Breyer JP; Smith JR; Rebbeck TR; Mercola D; Isaacs WB; Wiklund F; Cussenot O; Thibodeau SN; Schaid DJ; Cannon-Albright L; Cooney KA; Chanock SJ; Stanford JL; Chan JM; Witte J; Xu J; Bensen JT; Taylor JA; Catalona WJ
    Hum Genet; 2015 Apr; 134(4):439-50. PubMed ID: 25715684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy.
    Whitman EJ; Pomerantz M; Chen Y; Chamberlin MM; Furusato B; Gao C; Ali A; Ravindranath L; Dobi A; Sesterhenn IA; McLeod DG; Srivastava S; Freedman M; Petrovics G
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):1-8. PubMed ID: 20056617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population.
    Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Choi WS; Kim D; Kim HJ; Myung SC
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):149-56. PubMed ID: 24492489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the substrate specificity of human carboxypeptidase A4 and implications for a role in extracellular peptide processing.
    Tanco S; Zhang X; Morano C; Avilés FX; Lorenzo J; Fricker LD
    J Biol Chem; 2010 Jun; 285(24):18385-96. PubMed ID: 20385563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two genome-wide association studies of aggressive prostate cancer implicate putative prostate tumor suppressor gene DAB2IP.
    Duggan D; Zheng SL; Knowlton M; Benitez D; Dimitrov L; Wiklund F; Robbins C; Isaacs SD; Cheng Y; Li G; Sun J; Chang BL; Marovich L; Wiley KE; Bälter K; Stattin P; Adami HO; Gielzak M; Yan G; Sauvageot J; Liu W; Kim JW; Bleecker ER; Meyers DA; Trock BJ; Partin AW; Walsh PC; Isaacs WB; Grönberg H; Xu J; Carpten JD
    J Natl Cancer Inst; 2007 Dec; 99(24):1836-44. PubMed ID: 18073375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the innate immunity and inflammation pathway with advanced prostate cancer risk.
    Kazma R; Mefford JA; Cheng I; Plummer SJ; Levin AM; Rybicki BA; Casey G; Witte JS
    PLoS One; 2012; 7(12):e51680. PubMed ID: 23272139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
    Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.
    Langeberg WJ; Kwon EM; Koopmeiners JS; Ostrander EA; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):258-64. PubMed ID: 20056646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of mitochondrial genomic variation and associated clinical presentation of prostate cancer in South African men.
    McCrow JP; Petersen DC; Louw M; Chan EK; Harmeyer K; Vecchiarelli S; Lyons RJ; Bornman MS; Hayes VM
    Prostate; 2016 Mar; 76(4):349-58. PubMed ID: 26660354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxypeptidase A4 accumulation is associated with an aggressive phenotype and poor prognosis in triple-negative breast cancer.
    Handa T; Katayama A; Yokobori T; Yamane A; Fujii T; Obayashi S; Kurozumi S; Kawabata-Iwakawa R; Gombodorj N; Nishiyama M; Asao T; Shirabe K; Kuwano H; Oyama T
    Int J Oncol; 2019 Mar; 54(3):833-844. PubMed ID: 30628666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CD14 variant with prostate cancer in African American men.
    Mason TE; Ricks-Santi L; Chen W; Apprey V; Joykutty J; Ahaghotu C; Kittles R; Bonney G; Dunston GM
    Prostate; 2010 Feb; 70(3):262-9. PubMed ID: 19830784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population.
    Beikzadeh B; Angaji SA; Abolhasani M
    BMC Med Genet; 2020 Apr; 21(1):81. PubMed ID: 32295536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.